Cover Image.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 1, doi. 10.1002/iub.2709
- By:
- Publication type:
- Article
Works matching IS 15216543 AND DT 2023 AND VI 75 AND IP 2
Results: 10
1
2
Correction to "Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor".
- Published in:
- 2023
- Publication type:
- Correction Notice
3
Thiourea derivatives inhibit key diabetes‐associated enzymes and advanced glycation end‐product formation as a treatment for diabetes mellitus.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 161, doi. 10.1002/iub.2699
- By:
- Publication type:
- Article
4
MiR‐548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 97, doi. 10.1002/iub.2688
- By:
- Publication type:
- Article
5
Expanding role of ribosome‐inactivating proteins: From toxins to therapeutics.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 82, doi. 10.1002/iub.2675
- By:
- Publication type:
- Article
6
MST4 as a novel therapeutic target for autophagy and radiosensitivity in gastric cancer.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 117, doi. 10.1002/iub.2682
- By:
- Publication type:
- Article
7
Brucein D imparts a growth inhibitory effect in multiple myeloma cells by abrogating the Akt‐driven signaling pathway.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 149, doi. 10.1002/iub.2684
- By:
- Publication type:
- Article
8
N6‐methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 137, doi. 10.1002/iub.2678
- By:
- Publication type:
- Article
9
Issue Highlights.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 81, doi. 10.1002/iub.2629
- Publication type:
- Article
10
Issue Information.
- Published in:
- IUBMB Life, 2023, v. 75, n. 2, p. 77, doi. 10.1002/iub.2628
- Publication type:
- Article